Express News | Warm Autoimmune Hemolytic Anemia (Waiha) Research Presented by Johnson & Johnson Highlights Profound Disease Burden and Unmet Need for Targeted Treatment Options

Reuters08:00 ET

Institutional Investors May Adopt Severe Steps After Johnson & Johnson's (NYSE:JNJ) Latest 3.5% Drop Adds to a Year Losses

Yahoo Finance08:00 ET

Johnson & Johnson Says 2 Studies of Potential Early Multiple Myeloma Drug Showed 'Promising' Efficacy

MT Newswires06:30 ET

Johnson & Johnson Says Darzalex Faspro Shows Improved Outcomes in Multiple Myeloma Study

MT Newswires04:23 ET

Express News | Reported Sunday, Johnson & Johnson Highlights TECVAYLI's Role In Advancing Frontline Multiple Myeloma Care With 100% MRD-Negative Results At ASH 2024

Benzinga02:41 ET

This AI Robot Trader Loves Tesla and Other Trump Trades

Barrons01:00 ET